C. John Blankley

1.2k total citations
33 papers, 1.0k citations indexed

About

C. John Blankley is a scholar working on Molecular Biology, Surgery and Organic Chemistry. According to data from OpenAlex, C. John Blankley has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Surgery and 11 papers in Organic Chemistry. Recurrent topics in C. John Blankley's work include Lipoproteins and Cardiovascular Health (11 papers), Cholesterol and Lipid Metabolism (6 papers) and Computational Drug Discovery Methods (4 papers). C. John Blankley is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Cholesterol and Lipid Metabolism (6 papers) and Computational Drug Discovery Methods (4 papers). C. John Blankley collaborates with scholars based in United States, United Kingdom and Russia. C. John Blankley's co-authors include Herbert O. House, Alexander Chucholowski, Bruce D. Roth, Robert W. Fleming, M. L. HOEFLE, S. KLUTCHKO, John C. Hodges, Ronald D. Smith, Richard L. Stanfield and Drago R. Sliskovic and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Life Sciences.

In The Last Decade

C. John Blankley

32 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. John Blankley United States 17 510 419 132 123 114 33 1.0k
Johannes D. Aebi Switzerland 24 606 1.2× 1.1k 2.5× 162 1.2× 90 0.7× 50 0.4× 40 1.6k
Alexander Chucholowski Germany 14 670 1.3× 537 1.3× 41 0.3× 50 0.4× 89 0.8× 24 956
Barry C. Ross United Kingdom 16 372 0.7× 505 1.2× 58 0.4× 68 0.6× 95 0.8× 38 905
Samuel Chackalamannil United States 24 848 1.7× 504 1.2× 75 0.6× 59 0.5× 311 2.7× 75 1.7k
Claudio F. Sturino Canada 18 644 1.3× 355 0.8× 89 0.7× 32 0.3× 43 0.4× 29 1.1k
Bruce G. Szczepankiewicz United States 19 386 0.8× 904 2.2× 54 0.4× 102 0.8× 50 0.4× 32 1.4k
Rayomand J. Unwalla United States 19 395 0.8× 428 1.0× 132 1.0× 219 1.8× 19 0.2× 34 1.1k
Carmela Gnerre Switzerland 18 374 0.7× 288 0.7× 76 0.6× 81 0.7× 67 0.6× 39 1.1k
Gee‐Hong Kuo United States 22 540 1.1× 486 1.2× 106 0.8× 101 0.8× 20 0.2× 46 1.0k
Hiroaki Yanagisawa Japan 17 403 0.8× 411 1.0× 28 0.2× 57 0.5× 264 2.3× 46 998

Countries citing papers authored by C. John Blankley

Since Specialization
Citations

This map shows the geographic impact of C. John Blankley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. John Blankley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. John Blankley more than expected).

Fields of papers citing papers by C. John Blankley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. John Blankley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. John Blankley. The network helps show where C. John Blankley may publish in the future.

Co-authorship network of co-authors of C. John Blankley

This figure shows the co-authorship network connecting the top 25 collaborators of C. John Blankley. A scholar is included among the top collaborators of C. John Blankley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. John Blankley. C. John Blankley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaznessis, Yiannis N., Mark E. Snow, & C. John Blankley. (2001). Prediction of blood-brain partitioning using Monte Carlo simulations of molecules in water. Journal of Computer-Aided Molecular Design. 15(8). 697–708. 42 indexed citations
2.
Blankley, C. John. (1998). Measuring Molecular Diversity: Evaluation of Alternative Subsets Selected from Reagent Building Block Libraries for Combinatorial Chemistry. Pharmacy and Pharmacology Communications. 4(3). 139–146. 1 indexed citations
3.
Steinbaugh, Bruce A., Harriet W. Hamilton, J. V. N. Vara Prasad, et al.. (1996). A topliss tree analysis of the HIV-protease inhibitory activity of 6-phenyl-4-hydroxy-pyran-2-ones. Bioorganic & Medicinal Chemistry Letters. 6(10). 1099–1104. 11 indexed citations
4.
Roark, W. Howard, Janak Padia, Gary L. Bolton, et al.. (1995). Bioisosterism in drug design: Identification of and structure-activity relationships in a series of glycine anilide ACAT inhibitors. Bioorganic & Medicinal Chemistry. 3(1). 29–39. 3 indexed citations
5.
6.
Bisgaier, Charles L., et al.. (1994). Cholesteryl ester transfer protein inhibition by PD 140195. Lipids. 29(12). 811–818. 15 indexed citations
7.
Trivedi, Bharat K., Ann Holmes, C. John Blankley, et al.. (1993). Inhibitors of acyl-CoA:cholesterol acyltransferase. 4. A novel series of urea ACAT inhibitors as potential hypocholesterolemic agents. Journal of Medicinal Chemistry. 36(22). 3300–3307. 47 indexed citations
8.
Augelli‐Szafran, Corinne E., C. John Blankley, Bruce D. Roth, et al.. (1993). Inhibitors of acyl-CoA:cholesterol acyltransferase. 5. Identification and structure-activity relationships of novel .beta.-keto amides as hypocholesterolemic agents. Journal of Medicinal Chemistry. 36(20). 2943–2949. 22 indexed citations
9.
Sliskovic, Drago R., C. John Blankley, Brian R. Krause, et al.. (1992). Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted-pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-ones. Journal of Medicinal Chemistry. 35(11). 2095–2103. 16 indexed citations
10.
Hodges, John C., James M. Hamby, & C. John Blankley. (1992). ANGIOTENSIN II RECEPTOR BINDING INHIBITORS. 17. 575–593. 20 indexed citations
11.
Roth, Bruce D., C. John Blankley, M. L. HOEFLE, et al.. (1992). Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agents. Journal of Medicinal Chemistry. 35(9). 1609–1617. 57 indexed citations
12.
Trivedi, Bharat K., C. John Blankley, James A. Bristol, et al.. (1991). N6-Substituted adenosine receptor agonists: potential antihypertensive agents. Journal of Medicinal Chemistry. 34(3). 1043–1049. 28 indexed citations
13.
14.
15.
Roth, Bruce D., Thomas Bocan, C. John Blankley, et al.. (1991). Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase. Journal of Medicinal Chemistry. 34(1). 463–466. 46 indexed citations
16.
Blankley, C. John, John C. Hodges, S. KLUTCHKO, et al.. (1991). Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. Journal of Medicinal Chemistry. 34(11). 3248–3260. 131 indexed citations
17.
Blankley, C. John, et al.. (1987). Synthesis and structure activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acids. Journal of Medicinal Chemistry. 30(6). 992–998. 40 indexed citations
18.
Blankley, C. John. (1985). Chronicals of Drug Discovery, vol. 2. Journal of Pharmaceutical Sciences. 74(9). 1029–1030. 1 indexed citations
19.
Blankley, C. John & Harvey Kaplan. (1984). Biologically active phospholipids as potential cardiovascular drugs. Drug Development Research. 4(3). 351–372. 4 indexed citations
20.
House, Herbert O. & C. John Blankley. (1967). Perhydroindan derivatives. VII. Stereochemistry of bridgehead alkylation. The Journal of Organic Chemistry. 32(6). 1741–1748. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes D. Aebi Breakdown of academic impact, for papers by Alexander Chucholowski Breakdown of academic impact, for papers by Barry C. Ross Breakdown of academic impact, for papers by Samuel Chackalamannil Breakdown of academic impact, for papers by Claudio F. Sturino Breakdown of academic impact, for papers by Bruce G. Szczepankiewicz Breakdown of academic impact, for papers by Rayomand J. Unwalla Breakdown of academic impact, for papers by Carmela Gnerre Breakdown of academic impact, for papers by Gee‐Hong Kuo Breakdown of academic impact, for papers by Hiroaki Yanagisawa
Rankless by CCL
2026